name: pleckstrin homology domain-containing family G member 5 isoform h4 (human)

description: A pleckstrin homology domain-containing family G member 5 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:O94827-7.


dapper homolog 2 isoform h2 (human)

A dapper homolog 2 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q5SW24-2.


name: forkhead box protein O3, initiator methionine removed phosphorylated 1 (human)

description: A forkhead box protein O3 (human) that has had the initiator methionine removed and that has been phosphorylated on the residue at the position equivalent to Ser-215 of the amino acid sequence represented by UniProtKB:O43524-1. Example: UniProtKB:O43524-1, 2-673, Ser-215, MOD:00046.


name: probable purine permease 11 isoform 2 (Arabidopsis thaliana)

description: A probable purine permease 11 (Arabidopsis thaliana) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q9LPF6-2.


name: kinesin-like protein KIF7 deaminated 1 (human)

description: A kinesin-like protein KIF7 (human) that has been deaminated on the residue at the position equivalent to Gln-487 of the amino acid sequence represented by UniProtKB:Q2M1P5. UniProtKB:Q2M1P5, Gln-487, MOD:00685.


name: iodotyrosine deiodinase 1 isoform h1 (human)

description: An iodotyrosine deiodinase 1 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q6PHW0-1.


name: volume-regulated anion channel subunit LRRC8C phosphorylated 1 (human)

description: A volume-regulated anion channel subunit LRRC8C (human) that has been phosphorylated on the residue at the position equivalent to Ser-543 of the amino acid sequence represented by UniProtKB:Q8TDW0. UniProtKB:Q8TDW0, Ser-543, MOD:00046.


name: volume-regulated anion channel subunit LRRC8C

description: A protein that is a translation product of the human LRRC8C gene or a 1:1 ortholog thereof.


name: LRC8C_HUMAN Volume-regulated anion channel subunit LRRC8C (sprot)

description: A volume-regulated anion channel subunit LRRC8C that is encoded in the genome of human.


name: volume-regulated anion channel subunit LRRC8C isoform 1 (mouse)

description: A volume-regulated anion channel subunit LRRC8C isoform 1 that is encoded in the genome of mouse.


name: volume-regulated anion channel subunit LRRC8C O-glycosylated 2 (human)

description: A volume-regulated anion channel subunit LRRC8C (human) that has been O-glycosylated at the residue equivalent to Thr-79 of the amino acid sequence represented by UniProtKB:Q8TDW0-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:Q8TDW0-1, Thr-79, MOD:00005~GNO:G43417UB.


name: LRC8C_MOUSE Volume-regulated anion channel subunit LRRC8C (sprot)

description: A volume-regulated anion channel subunit LRRC8C that is encoded in the genome of mouse.


name: volume-regulated anion channel subunit LRRC8C cysteinylated 1 (human)

description: A volume-regulated anion channel subunit LRRC8C (human) that has been cysteinylated on the residue at the position equivalent to Cys-599 of the amino acid sequence represented by UniProtKB:Q8TDW0. UniProtKB:Q8TDW0, Cys-599, MOD:00765.


name: LRC8C_RAT Volume-regulated anion channel subunit LRRC8C (sprot)

description: A volume-regulated anion channel subunit LRRC8C that is encoded in the genome of rat.


name: volume-regulated anion channel subunit LRRC8C isoform 1 (human)

description: A volume-regulated anion channel subunit LRRC8C isoform 1 that is encoded in the genome of human.


name: volume-regulated anion channel subunit LRRC8C isoform 1

description: A volume-regulated anion channel subunit LRRC8C that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q8TDW0-1 or a 1:1 ortholog thereof.


name: volume-regulated anion channel subunit LRRC8C deaminated 3 (human)

description: A volume-regulated anion channel subunit LRRC8C (human) that has been deaminated on the residue at the position equivalent to Asn-70 of the amino acid sequence represented by UniProtKB:Q8TDW0. UniProtKB:Q8TDW0, Asn-70, MOD:00684.


name: volume-regulated anion channel subunit LRRC8C deaminated 1 (human)

description: A volume-regulated anion channel subunit LRRC8C (human) that has been deaminated on the residue at the position equivalent to Asn-468 of the amino acid sequence represented by UniProtKB:Q8TDW0. UniProtKB:Q8TDW0, Asn-468, MOD:00684.


name: volume-regulated anion channel subunit LRRC8C O-glycosylated 1 (human)

description: A volume-regulated anion channel subunit LRRC8C (human) that has been O-glycosylated at the residue equivalent to Ser-87 of the amino acid sequence represented by UniProtKB:Q8TDW0-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:Q8TDW0-1, Ser-87, MOD:00002~GNO:G43417UB.


name: volume-regulated anion channel subunit LRRC8C isoform 1 (rat)

description: A volume-regulated anion channel subunit LRRC8C isoform 1 that is encoded in the genome of rat.


name: volume-regulated anion channel subunit LRRC8C deaminated 2 (human)

description: A volume-regulated anion channel subunit LRRC8C (human) that has been deaminated on the residue at the position equivalent to Gln-709 of the amino acid sequence represented by UniProtKB:Q8TDW0. UniProtKB:Q8TDW0, Gln-709, MOD:00685.


name: cGMP-dependent protein kinase egl-4 isoform e (worm)

description: A cGMP-dependent protein kinase egl-4 (worm) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:O76360-5.


name: laminin subunit alpha-5 deaminated 1 (human)

description: A laminin subunit alpha-5 (human) that has been deaminated on the residue at the position equivalent to Gln-2253 of the amino acid sequence represented by UniProtKB:O15230-1. Example: UniProtKB:O15230-1, Gln-2253, MOD:00685.


name: LIM/homeobox protein lim-4 isoform a (worm)

description: A LIM/homeobox protein lim-4 (worm) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:G5EEA1-1.


paraflagellar rod assembly

category: biolink:BiologicalProcess biolink:Occurrent biolink:OntologyClass biolink:BiologicalProcessOrActivity biolink:BiologicalEntity biolink:ThingWithTaxon biolink:NamedThing biolink:PhysicalEssenceOrOccurrent

description: The aggregation, arrangement and bonding together of a set of components to form a paraflagellar rod, a large lattice-like axial structure found in some flagellated protists which extends alongside the axoneme.


sperm flagellum assembly

description: The assembly and organization of the sperm flagellum, the microtubule-based axoneme and associated structures that are part of a sperm flagellum (or cilium).


non-motile cilium assembly

description: The aggregation, arrangement and bonding together of a set of components to form a non-motile cilium.


motile cilium assembly

description: The aggregation, arrangement and bonding together of a set of components to form a motile cilium.


cytosolic ciliogenesis

description: The process in which an axoneme is exposed entirely or partially to the cytoplasm or by which the cytoplasmic portion is assembled or extended. Cytosolic ciliogenesis can occur following compartmentalized ciliogenesis, in which the cilium is formed within a compartment separated from the cytoplasm.


endrin

An organochlorine compound resulting from the epoxidation of the double bond of isodrin. It is the endo, endo stereoisomer of dieldrin. It is an insecticide mainly used on field crops such as cotton and grains and has also been used as a rodenticide to control mice and voles. The product is banned in many countries since it is a persistent organic pollutant.


name: facioscapulohumeral muscular dystrophy 1

category: biolink:Disease biolink:DiseaseOrPhenotypicFeature biolink:BiologicalEntity biolink:ThingWithTaxon biolink:NamedThing

description: Any facioscapulohumeral muscular dystrophy in which the cause of the disease is a mutation in the FRG1 gene.


FA98A_HUMAN Protein FAM98A (sprot)

A protein FAM98A that is encoded in the genome of human.


name: Ack-related non-receptor tyrosine kinase isoform b (worm)

description: An Ack-related non-receptor tyrosine kinase (worm) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:G5EBZ8-2.


name: tumor necrosis factor receptor superfamily member 12A

description: A protein that is a translation product of the human TNFRSF12A gene or a 1:1 ortholog thereof.


name: tumor necrosis factor receptor superfamily member 12A isoform h1 (human)

description: A tumor necrosis factor receptor superfamily member 12A (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q9NP84-1.


name: tumor necrosis factor receptor superfamily member 12A, signal peptide removed form (human)

description: A tumor necrosis factor receptor superfamily member 12A (human) that has had the signal peptide removed. UniProtKB:Q9NP84, 28-129.


name: tumor necrosis factor receptor superfamily member 12A isoform h2 (human)

description: A tumor necrosis factor receptor superfamily member 12A (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q9NP84-2.


cellular response to fructose stimulus

description: Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a fructose stimulus.


cellular response to glyceraldehyde

description: Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a glyceraldehyde stimulus.


cellular response to hexose stimulus

description: Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a hexose stimulus.


cellular response to D-galactose

description: Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a D-galactose stimulus.


name: cellular response to monosaccharide stimulus

description: Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a monosaccharide stimulus.


cellular response to mannose

description: Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a mannose stimulus.


cellular response to rhamnose stimulus

description: Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a rhamnose stimulus.


cellular response to glucose stimulus

description: Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a glucose stimulus.


name: mitochondrial import receptor subunit TOM20 homolog isoform 1 (rat)

description: A mitochondrial import receptor subunit TOM20 isoform 1 that is encoded in the genome of rat.


bacteriopheophytin a

A bacteriopheophytin consisting of bacteriochlorophyll a with two hydrogen atoms replacing the magnesium centre.


vimentin deaminated 5 (human)

A vimentin (human) that has been deaminated on the residue at the position equivalent to Gln-228 of the amino acid sequence represented by UniProtKB:P08670. UniProtKB:P08670, Gln-228, MOD:00685.


name: nuclear poly(A) polymerase 3 isoform 1 (Arabidopsis thaliana)

description: A nuclear poly(A) polymerase 3 (Arabidopsis thaliana) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q56XM9-1.


Gollop-Wolfgang complex

description: Gollop-Wolfgang complex is a very rare malformation characterized by ectrodactyly of the hand and ipsilateral bifurcation of the femur.


name: R51A2_HUMAN RAD51-associated protein 2 (sprot)

description: A RAD51-associated protein 2 that is encoded in the genome of human.


RAD51-associated protein 2

A protein that is a translation product of the human RAD51AP2 gene or a 1:1 ortholog thereof.


name: glucose-6-phosphate isomerase isoform 1 (Escherichia coli K-12)

description: A glucose-6-phosphate isomerase isoform 1 that is encoded in the genome of Escherichia coli K-12.


name: E3 ubiquitin-protein ligase MARCHF2 isoform 1 (mouse)

description: An E3 ubiquitin-protein ligase MARCHF2 isoform 1 that is encoded in the genome of mouse.


protein CD300H isoform h1 (human)

A protein CD300H (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:A0A0K2S4Q6-1.


CD3CH_HUMAN Protein CD300H (sprot)

A protein that is a translation product of the CD300H gene in human.


protein CD300H isoform h2 (human)

A protein CD300H (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:A0A0K2S4Q6-2.


name: cleavage and polyadenylation specificity factor subunit 6 isoform h2 (human)

description: A cleavage and polyadenylation specificity factor subunit 6 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q16630-2.


myricitrin-5-methyl ether

A monomethoxyflavone that is the 5-methyl ether derivative of myricitrin. Isolated from Rhododendron yedoense var poukhanense, it exhibits antioxidant activity.


name: RL72_ARATH Large ribosomal subunit protein uL30y (sprot)

description: A protein that is a translation product of the RPL7B gene in Arabidopsis thaliana.


name: large ribosomal subunit protein uL30y isoform 1 (Arabidopsis thaliana)

description: A large ribosomal subunit protein uL30y (Arabidopsis thaliana) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P60040-1.


integrin alpha-X deaminated 3 (human)

An integrin alpha-X (human) that has been deaminated on the residue at the position equivalent to Gln-570 of the amino acid sequence represented by UniProtKB:P20702. UniProtKB:P20702, Gln-570, MOD:00685.


Metastatic Salivary Duct Carcinoma

description: Salivary duct carcinoma that has spread from its original site of growth to another anatomic site.


Recurrent Salivary Duct Carcinoma

description: The reemergence of salivary duct carcinoma after a period of remission.


name: DNA-dependent metalloprotease SPRTN isoform h1 (human)

description: A DNA-dependent metalloprotease SPRTN (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q9H040-1.


DNA-dependent metalloprotease SPRTN

A protein that is a translation product of the human SPRTN gene or a 1:1 ortholog thereof.


name: DNA-dependent metalloprotease SPRTN isoform h2 (human)

description: A DNA-dependent metalloprotease SPRTN (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q9H040-2.


name: DNA-dependent metalloprotease SPRTN isoform h3 (human)

description: A DNA-dependent metalloprotease SPRTN (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q9H040-3.


lipase member K isoform m2 (mouse)

A lipase member K (mouse) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q8BM14-2.


name: sulfite oxidase, mitochondrial, transit peptide removed form (human)

description: A sulfite oxidase, mitochondrial (human) that has had the transit peptide removed. UniProtKB:P51687, 80-545.


SNX17_MOUSE Sorting nexin-17 (sprot)

A sorting nexin-17 that is encoded in the genome of mouse.


sorting nexin-17 isoform 1 (mouse)

A sorting nexin-17 isoform 1 that is encoded in the genome of mouse.


name: signal transducer and activator of transcription 6 methylated 1 (human)

description: A signal transducer and activator of transcription 6 (human) that has been methylated on the residue at the position equivalent to Cys-384 of the amino acid sequence represented by UniProtKB:P42226-1. Example: UniProtKB:P42226-1, Cys-384, MOD:00660.


name: tissue-type plasminogen activator N-glycosylated 16 (human)

description: A tissue-type plasminogen activator (human) that has been N-glycosylated at the residue equivalent to Asn-152 of the amino acid sequence represented by UniProtKB:P00750-1, in which the glycan structure is represented by GlyTouCan:G77038WW. Example: UniProtKB:P00750-1, Asn-152, MOD:00160~GNO:G77038WW.


name: microtubule-associated tumor suppressor candidate 2 isoform h3 (human)

description: A microtubule-associated tumor suppressor candidate 2 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q5JR59-4.


name: MVD1_SCHPO Diphosphomevalonate decarboxylase (sprot)

description: A diphosphomevalonate decarboxylase that is encoded in the genome of Schizosaccharomyces pombe 972h-.


name: zinc finger protein GLIS1 isoform m1 (mouse)

description: A zinc finger protein GLIS1 (mouse) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q8K1M4-1.


name: GLIS1_MOUSE Zinc finger protein GLIS1 (sprot)

description: A zinc finger protein GLIS1 that is encoded in the genome of mouse.


name: zinc finger protein GLIS1 isoform m2 (mouse)

description: A zinc finger protein GLIS1 (mouse) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q8K1M4-2.


name: peroxisomal membrane protein 11C isoform h2 (human)

description: A peroxisomal membrane protein 11C (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q96HA9-2.


name: ALDOC_RAT Fructose-bisphosphate aldolase C (sprot)

description: A fructose-bisphosphate aldolase C that is encoded in the genome of rat.


An aromatic ketone that is propiophenone substituted at position 3 by (4-bromophenyl)amino and 4-methoxyphenyl groups respectively.


YFCN_ECOLI UPF0115 protein YfcN (sprot)

A UPF0115 protein YfcN that is encoded in the genome of Escherichia coli K-12.


N-chimaerin isoform 1 (mouse)

An N-chimaerin isoform 1 that is encoded in the genome of mouse.


name: Stage I Rectal Neuroendocrine Tumor AJCC v8

description: Stage I includes: T1, N0, M0. T1: Tumor invading the lamina propria or submucosa and measuring 2 cm or less. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.)


CoA ester of bkas#38


name: DAF11_CAEEL Receptor-type guanylate cyclase daf-11 (sprot)

description: A protein that is a translation product of the daf-11 gene in worm.


name: TPM4_RAT Tropomyosin alpha-4 chain (sprot)

description: A tropomyosin alpha-4 chain that is encoded in the genome of rat.


name: tropomyosin alpha-4 chain isoform 1 (rat)

description: A tropomyosin alpha-4 chain isoform 1 that is encoded in the genome of rat.


name: FLOR1_ARATH Leucine-rich repeat protein FLOR 1 (sprot)

description: A protein that is a translation product of the FLR1 gene in Arabidopsis thaliana.


name: SO1A4_RAT Solute carrier organic anion transporter family member 1A4 (sprot)

description: A solute carrier organic anion transporter family member 1A4 that is encoded in the genome of rat.


name: FA2H_MOUSE Fatty acid 2-hydroxylase (sprot)

description: A fatty acid 2-hydroxylase that is encoded in the genome of mouse.


name: fatty acid 2-hydroxylase isoform 1 (mouse)

description: A fatty acid 2-hydroxylase isoform 1 that is encoded in the genome of mouse.


name: fatty acid 2-hydroxylase isoform m2 (mouse)

description: A fatty acid 2-hydroxylase (mouse) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q5MPP0-2.


name: fatty acid 2-hydroxylase isoform m3 (mouse)

description: A fatty acid 2-hydroxylase (mouse) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q5MPP0-3.


name: uncharacterized protein At3g60930, chloroplastic isoform 1 (Arabidopsis thaliana)

description: An uncharacterized protein At3g60930, chloroplastic (Arabidopsis thaliana) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q9LEX8-1.


name: alpha-tocopherol transfer protein isoform 1 (rat)

description: An alpha-tocopherol transfer protein isoform 1 that is encoded in the genome of rat.


name: acetylcholine receptor subunit delta isoform 1 (human)

description: An acetylcholine receptor subunit delta isoform 1 that is encoded in the genome of human.


name: ACHD_HUMAN Acetylcholine receptor subunit delta (sprot)

description: An acetylcholine receptor subunit delta that is encoded in the genome of human.


name: acetylcholine receptor subunit delta, signal peptide removed form (human)

description: An acetylcholine receptor subunit delta (human) that has had the signal peptide removed. UniProtKB:Q07001, 22-517.


name: acetylcholine receptor subunit delta isoform h2 (human)

description: An acetylcholine receptor subunit delta (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q07001-2.


name: tumor necrosis factor ligand superfamily member 15 isoform 2 (human)

description: A tumor necrosis factor ligand superfamily member 15 isoform 2 that is encoded in the genome of human.


name: tumor necrosis factor ligand superfamily member 15 isoform 2

description: A tumor necrosis factor ligand superfamily member 15 that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:O95150-2 or a 1:1 ortholog thereof.


name: E70E2_ARATH Exocyst complex component EXO70E2 (sprot)

description: A protein that is a translation product of the EXO70E2 gene in Arabidopsis thaliana.


name: Ral guanine nucleotide dissociation stimulator-like 1 isoform B (human)

description: A Ral guanine nucleotide dissociation stimulator-like 1 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q9NZL6-2.


name: Ral guanine nucleotide dissociation stimulator-like 1 isoform A (human)

description: A Ral guanine nucleotide dissociation stimulator-like 1 isoform 1 that is encoded in the genome of human.


name: UBA3_DICDI NEDD8-activating enzyme E1 catalytic subunit (sprot)

description: A NEDD8-activating enzyme E1 catalytic subunit that is encoded in the genome of Dictyostelium discoideum.


name: isoleucine--tRNA ligase, cytoplasmic methylated 1 (human)

description: An isoleucine--tRNA ligase, cytoplasmic (human) that has been methylated on the residue at the position equivalent to Cys-336 of the amino acid sequence represented by UniProtKB:P41252. UniProtKB:P41252, Cys-336, MOD:00660.


NRAM_I83A1 Neuraminidase (sprot)

A neuraminidase subtype N1 (Influenza A virus) that is encoded in the genome of the H1N1 strain A/Chile/1/1983.


name: extracellular matrix organizing protein FRAS1 isoform h5 (human)

description: An extracellular matrix organizing protein FRAS1 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q86XX4-5.


name: putative colanic acid biosynthesis glycosyl transferase WcaA

description: A protein that is a translation product of the Escherichia coli K-12 wcaA gene or a 1:1 ortholog thereof.


name: WCAA_ECOLI Putative colanic acid biosynthesis glycosyl transferase WcaA (sprot)

description: A putative colanic acid biosynthesis glycosyl transferase WcaA that is encoded in the genome of Escherichia coli K-12.


name: BRISC complex subunit Abraxas 2 isoform 1

description: A BRISC complex subunit Abraxas 2 that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q15018-1 or a 1:1 ortholog thereof.


name: BRISC complex subunit Abraxas 2 isoform 1 (human)

description: A BRISC complex subunit Abraxas 2 isoform 1 that is encoded in the genome of human.


name: BRISC complex subunit Abro1 isoform 1 (mouse)

description: A BRISC complex subunit Abraxas 2 isoform 1 that is encoded in the genome of mouse.


ski-like protein isoform SNOA (human)

A ski-like protein (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P12757-2.


A amino trisaccharide consisting of N-acetyl-D-glucosamine having an N-acetyl-alpha-D-galactosaminyl-(1->3)-beta-D-galactosyl group attached at the 4-position.


PRAX_RAT Periaxin (sprot)

A periaxin that is encoded in the genome of rat.


periaxin isoform 2 (rat)

A periaxin isoform 2 that is encoded in the genome of rat.


periaxin isoform r1 (rat)

A periaxin (rat) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q63425-1.


CIC-DUX4 Sarcoma

description: An undifferentiated, high grade small round cell sarcoma affecting predominantly young adults. It is characterized by a recurrent translocation involving the CIC gene on chromosome 19 and DUX4 gene on chromosome 4. The translocation results in CIC-DUX4, t(4;19)(q35;q13) fusions.


name: NUDE_ECOLI ADP compounds hydrolase NudE (sprot)

description: An ADP compounds hydrolase NudE that is encoded in the genome of Escherichia coli K-12.


name: HAUS augmin-like complex subunit 7 isoform h1 (human)

description: A HAUS augmin-like complex subunit 7 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q99871-1.


Senile dementia

description: Loss of intellectual abilities in an elderly person, interfering with this person's activities.


histone H2AX deaminated 1 (mouse)

A histone H2AX (mouse) that has been deaminated on the residue at the position equivalent to Gln-113 of the amino acid sequence represented by UniProtKB:P27661. UniProtKB:P27661, Gln-113, MOD:00685.


protein THEM6 isoform 1 (mouse)

A UPF0670 protein THEM6 isoform 1 that is encoded in the genome of mouse.


UPF0670 protein THEM6 isoform 1

A UPF0670 protein THEM6 that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q80ZW2-1 or a 1:1 ortholog thereof.


protein THEM6 isoform 1 (rat)

A UPF0670 protein THEM6 isoform 1 that is encoded in the genome of rat.


name: mast/stem cell growth factor receptor Kit sequence variant V560G, signal peptide removed form (human)

description: A mast/stem cell growth factor receptor Kit (human) that has a Gly residue at the position equivalent to Val-560 of the amino acid sequence represented by UniProtKB:P10721-1 and that has had the signal peptide removed. Example: UniProtKB:P10721-1, 26-976, Val-560, CHEBI:29947.


name: LBO1_ARATH Protein LATERAL BRANCHING OXIDOREDUCTASE 1 (sprot)

description: A protein that is a translation product of the LBO1 gene in Arabidopsis thaliana.


amide binding

category: biolink:MolecularActivity biolink:Occurrent biolink:OntologyClass biolink:BiologicalProcessOrActivity biolink:BiologicalEntity biolink:ThingWithTaxon biolink:NamedThing biolink:PhysicalEssenceOrOccurrent

description: Binding to an amide, any derivative of an oxoacid in which an acidic hydroxy group has been replaced by an amino or substituted amino group.


prostaglandin D2 receptor binding

description: Binding to a prostaglandin D2 receptor.


type 2 neuromedin U receptor binding

description: Binding to a type 2 neuromedin U receptor.


leukotriene receptor binding

description: Binding to a leukotriene receptor.


cysteinyl leukotriene receptor binding

description: Binding to a cysteinyl leukotriene receptor.


B1 bradykinin receptor binding

description: Binding to a B1 bradykinin receptor.


alpha-1D adrenergic receptor binding

description: Binding to an alpha-1D adrenergic receptor.


name: type 4 proteinase activated receptor binding

description: Binding to a type 4 proteinase activated receptor.


type 6 serotonin receptor binding

description: Binding to a type 6 serotonin receptor.


type 2B serotonin receptor binding

description: Binding to a type 2B serotonin receptor.


name: type 2 metabotropic GABA receptor binding

description: Binding to a type 2 metabotropic GABA receptor.


type 1 cannabinoid receptor binding

description: Binding to a type 1 cannabinoid receptor.


enzyme binding

description: Binding to an enzyme, a protein with catalytic activity.


name: Edg-2 lysophosphatidic acid receptor binding

description: Binding to an Edg-2 lysophosphatidic acid receptor.


type 2 somatostatin receptor binding

description: Binding to a type 2 somatostatin receptor.


substance P receptor binding

description: Binding to a substance P receptor.


type A cholecystokinin receptor binding

description: Binding to a type A cholecystokinin receptor.


type 1 angiotensin receptor binding

description: Binding to a type 1 angiotensin receptor.


type 2 neuropeptide Y receptor binding

description: Binding to a type 2 neuropeptide Y receptor.


D4 dopamine receptor binding

description: Binding to a D4 dopamine receptor.


alpha-2B adrenergic receptor binding

description: Binding to an alpha-2B adrenergic receptor.


proteinase activated receptor binding

description: Binding to a proteinase activated receptor.


P2Y10 nucleotide receptor binding

description: Binding to a P2Y10 nucleotide receptor.


P2Y8 nucleotide receptor binding

description: Binding to a P2Y8 nucleotide receptor.


thromboxane A2 receptor binding

description: Binding to a thromboxane A2 receptor.


name: G protein-coupled glutamate receptor binding

description: Binding to a G protein-coupled glutamate receptor (a metabotropic glutamate receptor).


type 1 somatostatin receptor binding

description: Binding to a type 1 somatostatin receptor.


name: corticotropin-releasing hormone receptor binding

description: Binding to a receptor for corticotropin-releasing hormone (CRH), a polypeptide hormone involved in the stress response. It is released by the hypothalamus and stimulates the release of corticotropin by the anterior pituitary gland.


name: G protein-coupled histamine receptor binding

description: Binding to a G protein-coupled (metabotropic) histamine receptor.


beta-endorphin receptor binding

description: Binding to a beta-endorphin receptor.


type 1B melatonin receptor binding

description: Binding to a type 1B melatonin receptor.


name: type B gastrin/cholecystokinin receptor binding

description: Binding to a type B gastrin/cholecystokinin receptor.


P2Y6 nucleotide receptor binding

description: Binding to a P2Y6 nucleotide receptor.


name: type 1 cysteinyl leukotriene receptor binding

description: Binding to a type 1 cysteinyl leukotriene receptor.


name: G protein-coupled acetylcholine receptor binding

description: Binding to a G protein-coupled acetylcholine receptor.


urotensin receptor binding

description: Binding to a urotensin receptor.


neuromedin K receptor binding

description: Binding to a neuromedin K receptor.


alpha-1A adrenergic receptor binding

description: Binding to an alpha-1A adrenergic receptor.


beta-3 adrenergic receptor binding

description: Binding to a beta-3 adrenergic receptor.


V2 vasopressin receptor binding

description: Binding to a V2 vasopressin receptor.


H3 histamine receptor binding

description: Binding to a H3 histamine receptor.


name: type 4 metabotropic glutamate receptor binding

description: Binding to a type 4 metabotropic glutamate receptor.


type 1 melanocortin receptor binding

description: Binding to a type 1 melanocortin receptor.


adrenergic receptor binding

description: Binding to an adrenergic receptor.


name: Edg-6 sphingosine 1-phosphate receptor binding

description: Binding to an Edg-6 sphingosine 1-phosphate receptor.


prostanoid receptor binding

description: Binding to a prostanoid receptor.


cholecystokinin receptor binding

description: Binding to a cholecystokinin receptor.


name: type 2 metabotropic glutamate receptor binding

description: Binding to a type 2 metabotropic glutamate receptor.


name: prolactin-releasing peptide receptor binding

description: Binding to a prolactin-releasing peptide receptor.


name: EP3 subtype prostaglandin E2 receptor binding

description: Binding to an EP3 subtype prostaglandin E2 receptor.


name: Edg-4 lysophosphatidic acid receptor binding

description: Binding to an Edg-4 lysophosphatidic acid receptor.


name: type 1 metabotropic glutamate receptor binding

description: Binding to a type 1 metabotropic glutamate receptor.


secretin receptor binding

description: Binding to a secretin receptor.


dopamine receptor binding

description: Binding to a dopamine receptor.


opioid receptor binding

description: Binding to an opioid receptor.


neuromedin U receptor binding

description: Binding to one or more specific sites on a neuromedin U receptor.


P2Y11 nucleotide receptor binding

description: Binding to a P2Y11 nucleotide receptor.


name: type 1 metabotropic GABA receptor binding

description: Binding to a type 1 metabotropic GABA receptor.


type 2C serotonin receptor binding

description: Binding to a type 2C serotonin receptor.


name: melanin-concentrating hormone receptor binding

description: Binding to a melanin-concentrating hormone receptor.


name: Edg-1 sphingosine 1-phosphate receptor binding

description: Binding to an Edg-1 sphingosine 1-phosphate receptor.


type 5B serotonin receptor binding

description: Binding to a type 5B serotonin receptor.


type 1 neuromedin U receptor binding

description: Binding to a type 1 neuromedin U receptor.


name: platelet activating factor receptor binding

description: Binding to a platelet activating factor receptor.


parathyroid hormone receptor binding

description: Binding to a parathyroid hormone receptor.


V1A vasopressin receptor binding

description: Binding to a V1A vasopressin receptor.


bombesin receptor binding

description: Binding to a bombesin receptor.


A2B adenosine receptor binding

description: Binding to an A2B adenosine receptor.


prostacyclin receptor binding

description: Binding to a prostacyclin receptor.


name: EP2 subtype prostaglandin E2 receptor binding

description: Binding to an EP2 subtype prostaglandin E2 receptor.


fMet-Leu-Phe receptor binding

description: Binding to a fMet-Leu-Phe receptor.


name: type 6 metabotropic glutamate receptor binding

description: Binding to a type 6 metabotropic glutamate receptor.


D3 dopamine receptor binding

description: Binding to a D3 dopamine receptor.


name: type 7 metabotropic glutamate receptor binding

description: Binding to a type 7 metabotropic glutamate receptor.


alpha-2C adrenergic receptor binding

description: Binding to an alpha-2C adrenergic receptor.


type 1 orexin receptor binding

description: Binding to a type 1 orexin receptor.


type 1B serotonin receptor binding

description: Binding to a type 1B serotonin receptor.


name: Edg-7 lysophosphatidic acid receptor binding

description: Binding to an Edg-7 lysophosphatidic acid receptor.


type 1 neurotensin receptor binding

description: Binding to a type 1 neurotensin receptor.


name: endothelial differentiation G protein-coupled receptor binding

description: Binding to an endothelial differentiation G protein-coupled receptor.


orexin receptor binding

description: Binding to an orexin receptor.


name: EP4 subtype prostaglandin E2 receptor binding

description: Binding to an EP4 subtype prostaglandin E2 receptor.


proctolin receptor binding

description: Binding to a proctolin receptor.


H9 melatonin receptor binding

description: Binding to a H9 melatonin receptor.


glucagon receptor binding

description: Binding to a glucagon receptor.


type 1 member 3 taste receptor binding

description: Binding to a type 1 member 3 taste receptor.


H2 histamine receptor binding

description: Binding to a H2 histamine receptor.


corazonin receptor binding

description: Binding to a corazonin receptor.


V1B vasopressin receptor binding

description: Binding to a V1B vasopressin receptor.


type 1 member 1 taste receptor binding

description: Binding to a type 1 member 1 taste receptor.


type 7 serotonin receptor binding

description: Binding to a type 7 serotonin receptor.


neuropeptide F receptor binding

description: Binding to a neuropeptide F receptor.


beta-2 adrenergic receptor binding

description: Binding to a beta-2 adrenergic receptor.


type 4 neuropeptide Y receptor binding

description: Binding to a type 4 neuropeptide Y receptor.


prostaglandin F2-alpha receptor binding

description: Binding to a prostaglandin F2-alpha receptor.


name: pituitary adenylate cyclase-activating polypeptide receptor binding

description: Binding to a pituitary adenylate cyclase-activating polypeptide receptor.


name: gastric inhibitory polypeptide receptor binding

description: Binding to a gastric inhibitory polypeptide receptor.


ubiquitin-specific protease binding

description: Binding to a ubiquitin-specific protease.


olfactory receptor binding

description: Binding to an olfactory receptor.


name: orexigenic neuropeptide QRFP receptor binding

description: Binding to an orexigenic neuropeptide QRFP receptor.


A3 adenosine receptor binding

description: Binding to an A3 adenosine receptor.


angiotensin receptor binding

description: Binding to an angiotensin receptor.


subtype 3 bombesin receptor binding

description: Binding to a subtype 3 bombesin receptor.


oxytocin receptor binding

description: Binding to an oxytocin receptor.


type 3 melanocortin receptor binding

description: Binding to a type 3 melanocortin receptor.


type 4 melanocortin receptor binding

description: Binding to a type 4 melanocortin receptor.


kisspeptin receptor binding

description: Binding to a kisspeptin receptor.


type 1D serotonin receptor binding

description: Binding to a type 1D serotonin receptor.


caspase binding

description: Binding to a caspase family protein.


endothelin B receptor binding

description: Binding to an endothelin B receptor.


adrenomedullin receptor binding

description: Binding to an adrenomedullin receptor.


name: type 1 melanin-concentrating hormone receptor binding

description: Binding to a type 1 melanin-concentrating hormone receptor.


name: thyrotropin-releasing hormone receptor binding

description: Binding to a receptor for thyrotropin-releasing hormone, a tripeptide hormone that is produced by the hypothalamus and stimulates the release of thyroid-stimulating hormone (TSH) and prolactin by the anterior pituitary.


vasopressin receptor binding

description: Binding to a vasopressin receptor.


name: type 2 vasoactive intestinal polypeptide receptor binding

description: Binding to a type 2 vasoactive intestinal polypeptide receptor.


cytoskeletal protein binding

description: Binding to a protein component of a cytoskeleton (actin, microtubule, or intermediate filament cytoskeleton).


mu-type opioid receptor binding

description: Binding to a mu-type opioid receptor.


name: type 5 metabotropic glutamate receptor binding

description: Binding to a type 5 metabotropic glutamate receptor.


cannabinoid receptor binding

description: Binding to a cannabinoid receptor.


P2Y2 nucleotide receptor binding

description: Binding to a P2Y2 nucleotide receptor.


type 3 galanin receptor binding

description: Binding to a type 3 galanin receptor.


type 5 somatostatin receptor binding

description: Binding to a type 5 somatostatin receptor.


neuropeptide receptor binding

description: Binding to a neuropeptide receptor.


galanin receptor binding

description: Binding to a galanin receptor.


bradykinin receptor binding

description: Binding to a bradykinin receptor.


smoothened binding

description: Binding to a smoothened (smo) protein, which interacts with patched to transmit hedgehog signals.


corticotropin hormone receptor binding

description: Binding to a corticotropin hormone receptor.


name: C5a anaphylatoxin chemotactic receptor binding

description: Binding to a C5a anaphylatoxin chemotactic receptor.


name: Edg-3 sphingosine 1-phosphate receptor binding

description: Binding to an Edg-3 sphingosine 1-phosphate receptor.


name: type 8 metabotropic glutamate receptor binding

description: Binding to a type 8 metabotropic glutamate receptor.


name: type 3 proteinase activated receptor binding

description: Binding to a type 3 proteinase activated receptor.


frizzled binding

description: Binding to a frizzled (fz) receptor.


name: follicle-stimulating hormone receptor binding

description: Binding to a follicle-stimulating hormone receptor.


H4 histamine receptor binding

description: Binding to a H4 histamine receptor.


apelin receptor binding

description: Binding to an apelin receptor.


type 5 neuropeptide Y receptor binding

description: Binding to a type 5 neuropeptide Y receptor.


name: growth hormone-releasing hormone receptor binding

description: Binding to a growth hormone-releasing hormone receptor.


name: C5L2 anaphylatoxin chemotactic receptor binding

description: Binding to a C5L2 anaphylatoxin chemotactic receptor.


microtubule lateral binding

description: Binding to the side of a microtubule.


type 1 member 2 taste receptor binding

description: Binding to a type 1 member 2 taste receptor.


name: type 2 melanin-concentrating hormone receptor binding

description: Binding to a type 2 melanin-concentrating hormone receptor.


tubulin binding

description: Binding to monomeric or multimeric forms of tubulin, including microtubules.


D5 dopamine receptor binding

description: Binding to a D5 dopamine receptor.


type 2 galanin receptor binding

description: Binding to a type 2 galanin receptor.


A1 adenosine receptor binding

description: Binding to an A1 adenosine receptor.


microtubule plus-end binding

description: Binding to the plus end of a microtubule.


type 1F serotonin receptor binding

description: Binding to a type 1F serotonin receptor.


type 5 melanocortin receptor binding

description: Binding to a type 5 melanocortin receptor.


D1 dopamine receptor binding

description: Binding to a D1 dopamine receptor.


signaling receptor binding

description: Binding to one or more specific sites on a receptor molecule, a macromolecule that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function.


P2Y1 nucleotide receptor binding

description: Binding to a P2Y1 nucleotide receptor.


type 4 serotonin receptor binding

description: Binding to a type 4 serotonin receptor.


name: polyubiquitin modification-dependent protein binding

description: Binding to a protein upon poly-ubiquitination of the target protein.


motilin receptor binding

description: Binding to a motilin receptor.


tachykinin receptor binding

description: Binding to a tachykinin receptor.


endothelin A receptor binding

description: Binding to an endothelin A receptor.


neurokinin receptor binding

description: Binding to a neurokinin receptor.


beta-1 adrenergic receptor binding

description: Binding to a beta-1 adrenergic receptor.


ghrelin receptor binding

description: Binding to a ghrelin receptor.


neuropeptide Y receptor binding

description: Binding to a neuropeptide Y receptor.


delta-type opioid receptor binding

description: Binding to a delta-type opioid receptor.


type 2A serotonin receptor binding

description: Binding to a type 2A serotonin receptor.


taste receptor binding

description: Binding to a taste receptor.


name: gastrin-releasing peptide receptor binding

description: Binding to a gastrin-releasing peptide receptor.


neurotensin receptor binding

description: Binding to a neurotensin receptor.


nociceptin receptor binding

description: Binding to a nociceptin receptor.


name: corticotropin-releasing hormone receptor 1 binding

description: Binding to a corticotropin-releasing hormone receptor 1 (CRHR1). CRHR1 is the major subtype in the pituitary corticotroph, and mediates the stimulatory actions of corticotropin-releasing hormone on corticotropin hormone secretion. CRHR1 are also located in cortical areas of the brain, cerebellum and limbic system.


name: type 1 parathyroid hormone receptor binding

description: Binding to a type 1 parathyroid hormone receptor.


name: lutropin-choriogonadotropic hormone receptor binding

description: Binding to a lutropin-choriogonadotropic hormone receptor.


name: type 1 proteinase activated receptor binding

description: Binding to a type 1 proteinase activated receptor.


alpha-latrotoxin receptor binding

description: Binding to an alpha-latrotoxin receptor.


type 1 neuropeptide Y receptor binding

description: Binding to a type 1 neuropeptide Y receptor.


type 2 orexin receptor binding

description: Binding to a type 2 orexin receptor.


B2 bradykinin receptor binding

description: Binding to a B2 bradykinin receptor.


kappa-type opioid receptor binding

description: Binding to a kappa-type opioid receptor.


alpha-2A adrenergic receptor binding

description: Binding to an alpha-2A adrenergic receptor.


D2 dopamine receptor binding

description: Binding to a D2 dopamine receptor.


type 1A melatonin receptor binding

description: Binding to a type 1A melatonin receptor.


neuromedin B receptor binding

description: Binding to a neuromedin B receptor.


type 1 galanin receptor binding

description: Binding to a type 1 galanin receptor.


calcitonin receptor binding

description: Binding to a calcitonin receptor.


type 2 cannabinoid receptor binding

description: Binding to a type 2 cannabinoid receptor.


P2Y4 nucleotide receptor binding

description: Binding to a P2Y4 nucleotide receptor.


type 3 somatostatin receptor binding

description: Binding to a type 3 somatostatin receptor.


substance K receptor binding

description: Binding to a substance K receptor.


type 5A serotonin receptor binding

description: Binding to a type 5A serotonin receptor.


name: type 1 vasoactive intestinal polypeptide receptor binding

description: Binding to a type 1 vasoactive intestinal polypeptide receptor.


P2Y9 nucleotide receptor binding

description: Binding to a P2Y9 nucleotide receptor.


somatostatin receptor binding

description: Binding to a somatostatin receptor.


name: vasoactive intestinal polypeptide receptor binding

description: Binding to a vasoactive intestinal polypeptide receptor.


type 1E serotonin receptor binding

description: Binding to a type 1E serotonin receptor.


type 2 angiotensin receptor binding

description: Binding to a type 2 angiotensin receptor.


melanocortin receptor binding

description: Binding to a melanocortin receptor.


H1 histamine receptor binding

description: Binding to a H1 histamine receptor.


alpha-1B adrenergic receptor binding

description: Binding to an alpha-1B adrenergic receptor.


A2A adenosine receptor binding

description: Binding to an A2A adenosine receptor.


name: type 3 metabotropic glutamate receptor binding

description: Binding to a type 3 metabotropic glutamate receptor.


melatonin receptor binding

description: Binding to a melatonin receptor.


adenosine receptor binding

description: Binding to an adenosine receptor.


name: type 2 proteinase activated receptor binding

description: Binding to a type 2 proteinase activated receptor.


name: type 2 cysteinyl leukotriene receptor binding

description: Binding to a type 2 cysteinyl leukotriene receptor.


name: Edg-5 sphingosine 1-phosphate receptor binding

description: Binding to an Edg-5 sphingosine 1-phosphate receptor.


name: corticotropin-releasing hormone receptor 2 binding

description: Binding to a corticotropin-releasing hormone receptor type 2 (CRHR2). The CRHR2 has several splice variants that are located in sub-cortical areas of the brain and in the periphery.


name: G protein-coupled nucleotide receptor binding

description: Binding to a G protein-coupled (metabotropic) nucleotide receptor.


protein binding

description: Binding to a protein.


modification-dependent protein binding

description: Binding to a protein upon post-translation modification of the target protein.


G protein-coupled GABA receptor binding

description: Binding to a G protein-coupled (metabotropic) GABA receptor.


name: G protein-coupled serotonin receptor binding

description: Binding to a metabotropic serotonin receptor.


phosphatidylethanolamine 32:0

A 1,2-diacyl-sn-glycero-3-phosphoethanolamine zwitterion in which the acyl groups at C-1 and C-2 contain 32 carbons in total with 0 double bonds.


A phosphatidylethanolamine 32:0 zwitterion obtained by transfer of a proton from the phosphate to the amino group of 1,2-dihexadecanoyl-sn-glycero-3-phosphoethanolamine.


KPYK2_ECOLI Pyruvate kinase II (sprot)

A pyruvate kinase II that is encoded in the genome of Escherichia coli K-12.


pyruvate kinase II

A protein that is a translation product of the Escherichia coli K-12 pykA gene or a 1:1 ortholog thereof.


name: pyruvate kinase II isoform 1, initiator methionine removed acetylated 1 (Escherichia coli K-12)

description: A pyruvate kinase II isoform 1, initiator methionine removed acetylated 1 in Escherichia coli K-12. UniProtKB:P21599-1, 2-480, Lys-351, MOD:00064.


name: pyruvate kinase II, initiator methionine removed form

description: A pyruvate kinase II that has had the initiator methionine removed.


name: pyruvate kinase II isoform 1 (Escherichia coli K-12)

description: A pyruvate kinase II isoform 1 that is encoded in the genome of Escherichia coli K-12.


name: pyruvate kinase II isoform 1, initiator methionine removed acetylated 1

description: A pyruvate kinase II isoform 1, initiator methionine removed form that has been acetylated at the position equivalent to Lys-351 of the amino acid sequence represented by UniProtKB:P21599-1. Example: UniProtKB:P21599-1, 2-480, Lys-351, MOD:00064.


name: pyruvate kinase II isoform 1, initiator methionine removed form

description: A pyruvate kinase II isoform 1 that has had the initiator methionine removed.


pyruvate kinase II isoform 1

A pyruvate kinase II that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P21599-1 or a 1:1 ortholog thereof.


name: bZIP transcription factor 29 isoform 2 (Arabidopsis thaliana)

description: A bZIP transcription factor 29 (Arabidopsis thaliana) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q8H1F0-2.


name: BZP29_ARATH bZIP transcription factor 29 (sprot)

description: A protein that is a translation product of the BZIP29 gene in Arabidopsis thaliana.


name: bZIP transcription factor 29 isoform 1 (Arabidopsis thaliana)

description: A bZIP transcription factor 29 (Arabidopsis thaliana) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q8H1F0-1.


LIPM_MOUSE Lipase member M (sprot)

A lipase member M that is encoded in the genome of mouse.


lipase member M

A protein that is a translation product of the human LIPM gene or a 1:1 ortholog thereof.


name: lipase member M, signal peptide removed form (human)

description: A lipase member M (human) that has had the signal peptide removed. UniProtKB:Q5VYY2, 34-423.


lipase member M isoform h2 (human)

A lipase member M (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q5VYY2-2.


name: lipase member M phosphorylated 1 (human)

description: A lipase member M (human) that has been phosphorylated on the residue at the position equivalent to Ser-138 of the amino acid sequence represented by UniProtKB:Q5VYY2-1. Example: UniProtKB:Q5VYY2-1, Ser-138, MOD:00046.


lipase member M isoform h1 (human)

A lipase member M (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q5VYY2-1.


lipase member M deaminated 1 (human)

A lipase member M (human) that has been deaminated on the residue at the position equivalent to Gln-84 of the amino acid sequence represented by UniProtKB:Q5VYY2-1. Example: UniProtKB:Q5VYY2-1, Gln-84, MOD:00685.


LIPM_HUMAN Lipase member M (sprot)

A lipase member M that is encoded in the genome of human.


Q20449_CAEEL Lipase (trembl)

A lipase member M that is encoded in the genome of worm.


name: interleukin-17 receptor E, signal peptide removed form (human)

description: An interleukin-17 receptor E (human) that has had the signal peptide removed. UniProtKB:Q8NFR9, 24-667.


name: PCKGC_RAT Phosphoenolpyruvate carboxykinase, cytosolic [GTP] (sprot)

description: A phosphoenolpyruvate carboxykinase, cytosolic [GTP] that is encoded in the genome of rat.


name: phosphoenolpyruvate carboxykinase, cytosolic [GTP] isoform 1 (rat)

description: A phosphoenolpyruvate carboxykinase, cytosolic [GTP] isoform 1 that is encoded in the genome of rat.


ubinuclein-1 isoform m1 (mouse)

A ubinuclein-1 (mouse) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q4G0F8-1.


name: zinc finger protein 644 deaminated 2 (human)

description: A zinc finger protein 644 (human) that has been deaminated on the residue at the position equivalent to Gln-1277 of the amino acid sequence represented by UniProtKB:Q9H582-1. Example: UniProtKB:Q9H582-1, Gln-1277, MOD:00685.


name: CR021_HUMAN UPF0711 protein C18orf21 (sprot)

description: A UPF0711 protein C18orf21 that is encoded in the genome of human.


name: UPF0711 protein C18orf21 isoform h1 (human)

description: A UPF0711 protein C18orf21 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q32NC0-1.


name: UPF0711 protein C18orf21 isoform h2 (human)

description: A UPF0711 protein C18orf21 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q32NC0-2.


name: Y1725_ARATH Putative receptor-like protein kinase At1g72540 (sprot)

description: A protein that is a translation product of the At1g72540 gene in Arabidopsis thaliana.


aminodiol

An amino alcohol having two hydroxy functional groups.


An aminodiol that is propane-1,3-diol substituted ny an amino and a methyl group at position 2.


C20 sphingosine

A sphingoid that is the C20 analogue of sphingosine.


N-lauryldiethanolamine

An aminodiol that is dodecylamine in which the amino hydrogens are replaced by 2-hydroxyethyl groups.


C17 sphingosine

A sphingoid that is the C17 analogue of sphingosine.


A 2-aminooctadecene-1,3-diol having its double bond at position 4.


A sphingoid that is hexadecasphing-4-enine substituted at position 15 by a methyl group.


An aminodiol composed of any octadecene having hydroxy functional groups at positions 1 and 3 and an amino substituent at position 2.


A sphingenine in which the C=C double bond is located at the 8-position.


C20 sphinganine

A 2-aminoicosane-1,3-diol having (2S,3R)-configuration.


sphingenine

A 2-aminooctadecene-1,3-diol having (2S,3R)-configuration.


An aminodiol that is cyclohexane-1,2-diol substituted at positions 3 and 5 by amino groups (the 1S,2S,3R,5S-diastereomer)


L-erythro-sphingosine

A (2R,3S)-2-aminooctadec-4-ene-1,3-diol in which the double bond has E geochemistry.


A 2-aminooctadec-4-ene-1,3-diol having (2R,3S)-configuration.


DIMETHYLSPINGOSINE

A sphingoid that is sphingosine in which the two amino hydrogens are replaced by methyl groups.


N-ethyldiethanolamine

A aminodiol that is diethanolamine in which the amino hydrogen has been replaced by an ethyl group. It is a metabolite of nitrogen mustards.


A sphingenine in which the C=C double bond is located at the 4-position.


alpha-(hydroxymethyl)serine

A serine derivative in which the alpha-hydrogen of serine is replaced by a hydroxymethyl group.


A sphingoid that is sphingosine having an additional cis-double bond at position 14.


fingolimod

An aminodiol that consists of propane-1,3-diol having amino and 2-(4-octylphenyl)ethyl substituents at the 2-position. It is a sphingosine 1-phosphate receptor modulator used for the treatment of relapsing-remitting multiple sclerosis. A prodrug, fingolimod is phosphorylated by sphingosine kinase to active metabolite fingolimod-phosphate, a structural analogue of sphingosine 1-phosphate.


tetradecasphinganine

A sphingoid obtained by formal hydrogenation of the C=C bond of tetradecasphingosine


A sphingoid that is the C16 analogue of sphingosine.


tetradecasphingosine

A sphingoid that is the C14-analogue of sphingosine.


An aminodiol that is octadecane bearing two hydroxy substituents at positions 1 and 3 as well as an amino substituent at position 2.


A sphingoid that is hexadecasphinganine substituted at position 15 by a methyl group.


DIISOPROPANOLAMINE

A secondary amino compound that is diethanolamine substituted by methyl groups at positions 1 and 1'. It is a versatile chemical used in a variety of personal care, cosmetic and industrial products.


sphingosine

A sphing-4-enine in which the double bond is trans.


An aminodiol that is icosane bearing two hydroxy substituents at positions 1 and 3 as well as an amino substituent at position 2.


hexadecasphinganine

A sphingoid obtained by formal hydrogenation of the C=C bond of hexadecasphingosine.


name: protein insertion into ER membrane by stop-transfer membrane-anchor sequence

description: A process of protein insertion into the endoplasmic reticulum (ER) membrane in which stop-transfer membrane-anchor sequences become an ER membrane spanning helix.


name: cell surface glycoprotein CD200 receptor 1, signal peptide removed form (human)

description: A cell surface glycoprotein CD200 receptor 1 (human) that has had the signal peptide removed. Example: UniProtKB:Q8TD46-1, 29-325.


A lactone which is 9-methyl-1,5-dioxonane-2,6-dione substituted by a benzyl group at position 8, a [(3-hydroxy-4-methoxypyridine-2-yl)carbonyl]amino group at position 3 and a (2-methylbut-2-enoyl)oxy group at position 7. It is isolated from the mycelia cake of Streptomyces sp. 517-02 and exhibits potent antifungal activity.


An amino oligosaccharide that is a branched tridecasaccharide derivative in which beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->2)-[beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->6)]-alpha-D-mannosyl and beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->2)-[beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->4)]-alpha-D-mannosyl branched pentasaccharide units are linked (1->6) and (1->3) respectively to the mannose residue of a beta-D-mannosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->4)-N-acetyl-beta-D-glucosamine trisaccharide.


name: corrinoid adenosyltransferase MMAB sequence variant R186W, transit peptide removed form (human)

description: A corrinoid adenosyltransferase MMAB (human) that has a Trp residue at the position equivalent to Arg-186 of the amino acid sequence represented by UniProtKB:Q96EY8 and that has had the transit peptide removed. UniProtKB:Q96EY8, 33-250, Arg-186, CHEBI:29954.


corrinoid adenosyltransferase MMAB

A protein that is a translation product of the human MMAB gene or a 1:1 ortholog thereof.


name: MMAB_MOUSE Corrinoid adenosyltransferase MMAB (sprot)

description: A corrinoid adenosyltransferase MMAB that is encoded in the genome of mouse.


name: corrinoid adenosyltransferase MMAB sequence variant R191W, transit peptide removed form (human)

description: A corrinoid adenosyltransferase MMAB (human) that has a Trp residue at the position equivalent to Arg-191 of the amino acid sequence represented by UniProtKB:Q96EY8 and that has had the transit peptide removed. UniProtKB:Q96EY8, 33-250, Arg-191, CHEBI:29954.


name: corrinoid adenosyltransferase MMAB isoform m2 (mouse)

description: A corrinoid adenosyltransferase MMAB (mouse) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q9D273-2.


name: corrinoid adenosyltransferase MMAB sequence variant E193L, transit peptide removed form (human)

description: A corrinoid adenosyltransferase MMAB (human) that has a Leu residue at the position equivalent to Glu-193 of the amino acid sequence represented by UniProtKB:Q96EY8 and that has had the transit peptide removed. UniProtKB:Q96EY8, 33-250, Glu-193, CHEBI:30006.


name: corrinoid adenosyltransferase MMAB isoform m1 (mouse)

description: A corrinoid adenosyltransferase MMAB (mouse) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q9D273-1.


name: MMAB_HUMAN Corrinoid adenosyltransferase MMAB (sprot)

description: A corrinoid adenosyltransferase MMAB that is encoded in the genome of human.


name: corrinoid adenosyltransferase MMAB, transit peptide removed form (human)

description: A corrinoid adenosyltransferase MMAB (human) that has had the transit peptide removed. UniProtKB:Q96EY8, 33-250.


name: 5-hydroxytryptamine receptor 2A isoform h2 (human)

description: A 5-hydroxytryptamine receptor 2A (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P28223-2.


name: SPT7_YEAST Transcriptional activator SPT7 (sprot)

description: A protein that is a translation product of the SPT7 gene in yeast.


name: chronic lymphocytic leukemia/small lymphocytic lymphoma

description: An indolent, mature B-cell neoplasm composed of small, round B-lymphocytes. When the bone marrow and peripheral blood are involved, the term chronic lymphocytic leukemia is used. The term small lymphocytic lymphoma is restricted to cases which do not show leukemic involvement of the bone marrow and peripheral blood.


hairy cell leukemia

description: Hairy cell leukemia (HCL) is a rare type of leukemia in which abnormal B-lymphocytes are present in the bone marrow, spleen and peripheral blood. It is a slowly progressive chronic lymphocytic leukemia (CLL). The name comes from the abnormally shaped lymphocytes with hair-like projections.


name: intrapelvic lymph node leukemic reticuloendotheliosis


refractory hairy cell leukemia

description: Hairy cell leukemia that is resistant to treatment.


name: pregerminal center chronic lymphocytic leukemia/small lymphocytic lymphoma

description: A recently recognized variant of chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) that lacks somatic hypermutations of the Immunoglobulin heavy chain (IGH) genes, implying pregerminal center B-cell origin. Microarray gene expression profiling studies have demonstrated the expression of ZAP-70 gene (Syk family tyrosine kinase) in this subset of CLL/CLL. Patients with this variant of CLL/SLL have an unfavorable prognosis compared to those with somatic hypermutations of the IGH genes, with a median survival of approximately 6-8 years.


name: chronic lymphocytic leukemia/small lymphocytic lymphoma with immunoglobulin heavy chain variable-region gene somatic hypermutation

description: A recently recognized variant of chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) expressing somatic hypermutations of the Immunoglobulin heavy chain (IGH) genes. The recognition of this variant alters the belief that CLL/SLL is always derived from a naive, pregerminal center B-cell. The presence of somatic hypermutations of IGH genes occurs in approximately 50% of CLL/SLL cases and implies a postgerminal center, memory origin. Patients with this variant of CLL/SLL have a favorable prognosis, with a reported median survival of more than 24 years.


hairy cell leukemia variant

description: Hairy Cell Leukemia variant (HCL-V) is defined as a rare and indolent form of small, mature, B-cell leukemia characterized by splenomegaly, an elevated white blood cell (WBC) count and hyper-cellular bone marrow. HCL-V is more aggressive and resistant to therapy than classical HCL (HCL-C).


GAG_HV1B1 Gag polyprotein (sprot)

A lentivirus-type gag polyprotein that is encoded in the genome of Human immunodeficiency virus type 1 group M subtype B (isolate BH10).


name: protein turtle homolog A isoform h2 (human)

description: A protein turtle homolog A (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q9P2J2-2.


name: TUTLA_HUMAN Protein turtle homolog A (sprot)

description: A protein turtle homolog A that is encoded in the genome of human.


name: protein turtle homolog A isoform 1 (human)

description: A protein turtle homolog A isoform 1 that is encoded in the genome of human.


A tetrahydrofolyl-poly(glutamate) macromolecule in which the glutamate residues all have L-configuration.


name: leucine-rich repeat and fibronectin type III domain-containing protein 1 isoform 1 (zebrafish)

description: A leucine-rich repeat and fibronectin type III domain-containing protein 1 (zebrafish) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q6PGX3-1.


name: RL26_DICDI Large ribosomal subunit protein uL24 (sprot)

description: A protein that is a translation product of the rpl26 gene in Dictyostelium discoideum.


name: SNW domain-containing protein 1, initiator methionine removed form (human)

description: A SNW domain-containing protein 1 (human) that has had the initiator methionine removed. UniProtKB:Q13573, 2-536.


disodium clodronate tetrahydrate

The tetrahydrate of the disodium salt of clodronic acid. It inhibits bone resorption and soft tissue calcification, and is used as an adjunct in the treatment of severe hypercalcaemia associated with malignancy, and in the management of osteolytic lesions and bone pain associated with skeletal metastases.


name: PDX2_DICDI Probable pyridoxal 5'-phosphate synthase subunit pdx2 (sprot)

description: A protein that is a translation product of the pdx2 gene in Dictyostelium discoideum.


name: Ras-related protein Rab-24 isoform 1 (mouse)

description: A Ras-related protein Rab-24 isoform 1 that is encoded in the genome of mouse.


Ras-related protein Rab-24 isoform 1

A Ras-related protein Rab-24 that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q969Q5-1 or a 1:1 ortholog thereof.


name: Ras-related protein Rab-24 isoform 1 (human)

description: A Ras-related protein Rab-24 isoform 1 that is encoded in the genome of human.


haptoglobin N-glycosylated 8 (human)

A haptoglobin (human) that has been N-glycosylated at the residue equivalent to Asn-184 of the amino acid sequence represented by UniProtKB:P00738-1, in which the glycan structure is represented by GlyTouCan:G31118FR. Example: UniProtKB:P00738-1, Asn-184, MOD:00160~GNO:G31118FR.


name: RS21_DANRE Small ribosomal subunit protein eS21 (sprot)

description: A small ribosomal subunit protein eS21 that is encoded in the genome of zebrafish.


name: small ribosomal subunit protein eS21 isoform 1 (zebrafish)

description: A small ribosomal subunit protein eS21 isoform 2 that is encoded in the genome of zebrafish.


name: large ribosomal subunit protein mL50 isoform h1 (human)

description: A large ribosomal subunit protein mL50 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q8N5N7-1.


name: WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1 isoform 1 (rat)

description: A WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1 isoform 1 that is encoded in the genome of rat.


name: all trans-polyprenyl-diphosphate synthase PDSS2 isoform 1 (rat)

description: An all trans-polyprenyl-diphosphate synthase PDSS2 isoform 1 that is encoded in the genome of rat.


name: DLP1_RAT All trans-polyprenyl-diphosphate synthase PDSS2 (sprot)

description: An all trans-polyprenyl-diphosphate synthase PDSS2 that is encoded in the genome of rat.


name: partner and localizer of BRCA2 sequence variant W1140G (human)

description: A partner and localizer of BRCA2 (human) that has a Gly residue at the position equivalent to Trp-1140 of the amino acid sequence represented by UniProtKB:Q86YC2. UniProtKB:Q86YC2, Trp-1140, CHEBI:29947.


pars planitis

description: An inflammatory disorder of the cilliary body in the uvea that affects healthy, younger individuals who are often asymptomatic. It has a long clinical course with relapses and remissions. Symptoms include mildly decreased vision and floaters. It may be associated with autoimmune disorders.


name: transcriptional enhancer factor TEF-5, initiator methionine removed form (human)

description: A transcriptional enhancer factor TEF-5 (human) that has had the initiator methionine removed. UniProtKB:Q99594, 2-435.


name: Breast Classic Lobular Carcinoma In Situ Type B

description: Breast classic lobular carcinoma in situ  characterized by the presence of neoplastic cells with nuclei of various sizes and shapes.


name: Early Stage HER2-Negative Breast Carcinoma

description: A HER2-negative breast adenocarcinoma that has not spread beyond the breast and the axillary lymph nodes.


name: Prognostic Stage IIIA Breast Cancer AJCC v8

description: Stage IIIA includes: (T0-1, N1, M0, G2, HER2 Status: Negative, ER Status: Negative, PR Status: Negative); (T0-1, N1, M0, G3, HER2 Status: Negative, ER Status: Positive, PR Status: Negative); (T0-1, N1, M0, G3, HER2 Status: Negative, ER Status: Negative, PR Status: Any); (T2, N0, M0, G2, HER2 Status: Negative, ER Status: Negative, PR Status: Negative); (T2, N0, M0, G3, HER2 Status: Negative, ER Status: Positive, PR Status: Negative); (T2, N0, M0, G3, HER2 Status: Negative, ER Status: Negative, PR Status: Any); (T2, N1, M0, G1, HER2 Status: Negative, ER Status: Positive, PR Status: Negative); (T2, N1, M0, G2, HER2 Status: Positive, ER Status: Negative, PR Status: Negative); (T2, N1, M0, G2, HER2 Status: Negative, ER Status: Positive, PR Status: Negative); (T2, N1, M0, G3, HER2 Status: Positive, ER Status: Positive, PR Status: Negative); (T2, N1, M0, G3, HER2 Status: Positive, ER Status: Negative, PR Status: Negative); (T3, N0, M0, G1, HER2 Status: Negative, ER Status: Positive, PR Status: Negative); (T3, N0, M0, G2, HER2 Status: Positive, ER Status: Negative, PR Status: Negative); (T3, N0, M0, G2, HER2 Status: Negative, ER Status: Positive, PR Status: Negative); (T3, N0, M0, G3, HER2 Status: Positive, ER Status: Positive, PR Status: Negative); (T3, N0, M0, G3, HER2 Status: Positive, ER Status: Negative, PR Status: Negative); (T0-2, N2, M0, G1, HER2 Status: Positive, ER Status: Positive, PR Status: Negative); (T0-2, N2, M0, G1, HER2 Status: Positive, ER Status: Negative, PR Status: Any); (T0-2, N2, M0, G1, HER2 Status: Negative, ER Status: Positive, PR Status: Negative); (T0-2, N2, M0, G1, HER2 Status: Negative, ER Status: Negative, PR Status: Positive); (T0-2, N2, M0, G2, HER2 Status: Positive, ER Status: Positive, PR Status: Negative); ( T0-2, N2, M0, G2, HER2 Status: Positive, ER Status: Negative, PR Status: Any); (T3, N1-2, M0, G1, HER2 Status: Positive, ER Status: Positive, PR Status: Negative); (T3, N1-2, M0, G1, HER2 Status: Positive, ER Status: Negative, PR Status: Any); (T3, N1-2, M0, G1, HER2 Status: Negative, ER Status: Positive, PR Status: Negative); (T3, N1-2, M0, G1, HER2 Status: Negative, ER Status: Negative, PR Status: Positive); (T3, N1-2, M0, G2, HER2 Status: Positive, ER Status: Positive, PR Status: Negative); (T3, N1-2, M0, G2, HER2 Status: Positive, ER Status: Negative, PR Status: Any); (T4, N0-2, M0, G1, HER2 Status: Negative, ER Status: Positive, PR Status: Positive); (Any T, N3, M0, G1, HER2 Status: Negative, ER Status: Positive, PR Status: Positive). T0: No evidence of primary tumor. T1: Tumor measuring 20 mm or less in greatest dimension. T2: Tumor measuring more than 20 mm, but not more than 50 mm in greatest dimension. T3: Tumor measuring more than 50 mm in greatest dimension. T4: Tumor of any size with direct extension to the chest wall and/or to the skin (ulceration or macroscopic nodules); invasion of the dermis alone does not qualify as T4. N0: No regional lymph node metastasis is identified or isolated tumor cell clusters (ITCs) are identified only. N1: Tumor with micrometastases; or metastases in 1-3 axillary lymph nodes; and/or clinically negative internal mammary nodes with micrometastases or macrometastases by sentinel lymph node biopsy. N2: Tumor with metastases in 4-9 axillary lymph nodes; or positive ipsilateral internal mammary lymph nodes by imaging in the absence of axillary lymph node metastases. N3: Tumor with metastases in 10 or more axillary lymph nodes; or in infraclavicular (level III axillary) lymph nodes; or positive ipsilateral internal mammary lymph nodes by imaging in the presence of one or more positive level I, II axillary lymph nodes; or in more than three axillary lymph nodes and micrometastases or macrometastases by sentinel lymph node biopsy in clinically negative ipsilateral internal mammary lymph nodes; or in ipsilateral supraclavicular lymph nodes. G1: Low combined histologic grade (favorable); SBR score of 3-5 points. G2: Intermediate combined histologic grade (moderately favorable); SBR score: 6-7 points. G3: High combined histologic grade (unfavorable); SBR score of 8-9 points. M0: No clinical or radiographic evidence of distant metastases. Imaging studies are not required to assign the M0 category. (AJCC 8th ed.)


name: Breast Ductal Carcinoma In Situ and Invasive Lobular Carcinoma

description: A breast carcinoma characterized by the presence of a ductal carcinoma in situ component and an invasive lobular carcinomatous component.


Localized Breast Carcinoma

description: Breast carcinoma that is confined to the site in which it initially manifested without evidence of spread to other anatomic sites.


Invasive Breast Cribriform Carcinoma

description: An invasive adenocarcinoma of the breast with a favorable clinical outcome, characterized by the presence of a sieve-like or cribriform infiltrating pattern.


name: Intraductal Micropapillary Breast Carcinoma

description: Breast ductal carcinoma in situ characterized by the presence of neoplastic epithelial cells arranged in micropapillary patterns.


name: Solid papillary carcinoma in situ of breast

description: Breast solid papillary carcinoma characterized by the presence of nodules with rounded, well-circumscribed contours and a distribution pattern consistent with an in situ process. (WHO 2019)


Stage IIA Breast Carcinoma

description: Stage IIA includes: (T0, N1, M0); (T1, N1, M0); (T2, N0, M0).  T0: No evidence of primary tumor.  T1: Tumor 20 mm or less in greatest dimension.  T1 includes T1mi. T1mi: Tumor 1 mm or less in greatest dimension. T2: Tumor more than 20 mm but not more than 50 mm in greatest dimension.  N1: Metastasis to movable ipsilateral level I, II axillary lymph node(s).  N0: No regional lymph node metastasis.  M0: No clinical or radiographic evidence of distant metastasis.  M0 includes M0(i+).  (AJCC 6th and 7th Eds.)


Stage IIIC Breast Cancer AJCC v7

description: Stage IIIC includes: Any T, N3, M0.  N3: Metastases in ipsilateral infraclavicular (level III) axillary lymph nodes(s) with or without level I, II axillary lymph node involvement; or in clinically detected ipsilateral internal mammary lymph node(s) with clinically evident level I, II axillary lymph node metastases; or metastases in ipsilateral supraclavicular lymph node(s) with or without axillary or internal mammary lymph node involvement.  M0: No clinical or radiographic evidence of distant metastasis.  M0 includes M0(i+).  (AJCC 7th Ed.)


name: Recurrent Hormone Receptor-Negative Breast Carcinoma

description: The reemergence of hormone receptor-negative breast carcinoma after a period of remission.


breast angiosarcoma

description: A malignant vascular neoplasm arising from the breast.


name: Invasive Breast Lobular Carcinoma, Solid Variant

description: A grade I invasive lobular carcinoma of the breast, characterized by the presence of neoplastic cells that form trabeculae and groups infiltrating collagen bundles.


name: Metastatic Triple-Negative Breast Carcinoma

description: A triple-negative breast carcinoma that has spread from its original site of growth to another anatomic site.


name: Invasive Breast Lobular Carcinoma with Predominant In Situ Component

description: A breast carcinoma characterized by the presence of a predominant lobular carcinoma in situ component and a minor component of invasive carcinoma.


Recurrent Malignant Breast Neoplasm

description: The reemergence of a malignant breast neoplasm after a period of remission.


name: Invasive Breast Lobular Carcinoma, Alveolar Variant

description: A grade I invasive lobular carcinoma of the breast, characterized by the presence of round groups of neoplastic cells.


Hereditary Female Breast Carcinoma

description: Breast carcinoma that has developed in female relatives of patients with history of breast carcinoma.


name: High Grade Ductal Breast Carcinoma In Situ

description: Breast ductal carcinoma in situ characterized by the presence of neoplastic cells with severe dysplasia and the formation of micropapillary, cribriform, or solid patterns. The nuclei show marked pleomorphism and have prominent nucleoli. Mitotic activity is usually present. There is comedo-type of necrosis present in the ducts. The necrotic debris is surrounded by pleomorphic malignant cells.


name: Breast Carcinoma Metastatic in the Liver

description: A carcinoma that originates from the breast and has spread to the liver.


name: Unresectable HER2-Negative Breast Carcinoma

description: A HER2-negative breast adenocarcinoma that is not amenable to surgical resection.


Recurrent Breast Mucinous Carcinoma

description: The reemergence of breast mucinous carcinoma after a period of remission.


Histiocytoid Breast Carcinoma

description: A rare variant of invasive lobular breast carcinoma characterized by the presence of histiocyte-like malignant cells with pale cytoplasm forming sheets or linear patterns. Apocrine differentiation may be present. It usually has an aggressive clinical course.


name: Squamous Cell Carcinoma In Situ of the Nipple

description: An intraepidermal squamous cell carcinoma involving the area of the nipple.


malignant neoplasm of breast stage I

description: Stage I includes: IA: T1, N0, M0 and IB: (T0, N1mi, M0); (T1, N1mi, M0).  T1: Tumor 20 mm or less in greatest dimension.  T1 includes T1mi. T1mi: Tumor 1 mm or less in greatest dimension.  T0: No evidence of primary tumor.  N0: No regional lymph node metastasis.  N1mi: Nodal micrometastases.  M0: No clinical or radiographic evidence of distant metastasis.  M0 includes M0(i+).  (AJCC 7th Ed.)


name: Prognostic Stage 0 Breast Cancer AJCC v8

description: Stage 0 includes: Tis, N0, M0, G1-3, HER2 Status: Any, ER Status: Any, PR Status: Any. Tis: Ductal carcinoma in situ. Lobular carcinoma in situ is a benign entity and is removed from TNM staging in the AJCC Cancer Staging Manual, 8th Edition. N0: No regional lymph node metastasis is identified or isolated tumor cell clusters (ITCs) are identified only. G1: Low combined histologic grade (favorable); SBR score of 3-5 points. G2: Intermediate combined histologic grade (moderately favorable); SBR score: 6-7 points. G3: High combined histologic grade (unfavorable); SBR score of 8-9 points. M0: No clinical or radiographic evidence of distant metastases. Imaging studies are not required to assign the M0 category. (AJCC 8th ed.)


Locally Recurrent Breast Carcinoma

description: The reemergence of breast carcinoma after a period of remission, at or adjacent to the site of the original tumor.


name: Refractory HER2-Positive Breast Carcinoma

description: HER2-positive breast carcinoma that is resistant to treatment.


name: Invasive Breast Solid Papillary Carcinoma

description: Breast solid papillary carcinoma associated with areas featuring strands or large clusters of tumor cells. (WHO 2019)


Breast Florid Lobular Carcinoma In Situ

description: Breast lobular carcinoma in situ characterized by the presence of neoplastic cells with cytological features identical to classic lobular carcinoma in situ, but with marked distention of terminal ductal lobular units or ducts.


name: adenocarcinoma of breast with neuroendocrine differentiation

description: An invasive breast carcinoma characterized by the presence of focal neuroendocrine differentiation.


name: Metastatic Breast Inflammatory Carcinoma

description: Inflammatory carcinoma of the breast that has spread from its original site of growth to another anatomic site.


name: Metastatic Breast Neuroendocrine Tumor G1

description: A well differentiated neuroendocrine tumor that arises from the breast and has metastasized to other anatomic sites.


Stage IV Breast Cancer AJCC v6 and v7

description: Stage IV includes: Any T, Any N, M1.  M1: Distant metastasis. (AJCC 6th and 7th Eds.)


name: Unresectable Hormone Receptor-Negative Breast Carcinoma

description: Hormone receptor-negative breast carcinoma that is not amenable to surgical resection.


name: Breast Classic Lobular Carcinoma In Situ

description: Breast lobular carcinoma in situ characterized by the presence of dyscohesive proliferations of type A and/or type B epithelial cells. Type A cells are small cells with uniform hyperchromatic nuclei, whereas type B cells have slightly larger vesicular nuclei, with mild variability in size and shape and with small nucleoli. The cell populations may be mixed in individual proliferations. (WHO 2019)


Atypical Medullary Breast Carcinoma

description: An invasive ductal breast carcinoma characterized by the presence of a predominantly syncytial architectural pattern. It may have some, but not all the strictly defined additional morphologic criteria which are necessary for the diagnosis of medullary breast carcinoma (presence of a diffuse lymphoplasmacytic infiltrate, neoplastic round cells with abundant cytoplasm and vesicular nuclei, complete histological circumscription, and absence of glandular or tubular structures). It does not have the relatively favorable outcome that characterizes medullary breast carcinoma.


name: Refractory Hormone Receptor-Negative Breast Carcinoma

description: Hormone receptor-negative breast carcinoma that is resistant to treatment.


Breast Periductal Stromal Tumor

description: A rare, low-grade malignant stromal tumor that arises from the breast. It is characterized by the proliferation of atypical stromal spindle cells that surround benign tubules and ducts in a pericanalicular pattern. Mitotic activity is present. The tumor has a multinodular and infiltrative growth pattern and lacks the leaf-like architecture of phyllodes tumor. Wide excision with negative margins is the treatment of choice.


Primary angiosarcoma of breast

description: An angiosarcoma that arises from the breast parenchyma and is not associated with radiation exposure.


name: Metastatic HER2-Negative Breast Carcinoma

description: A HER2-negative breast adenocarcinoma that has spread to another anatomic site.


name: Recurrent HER2-Positive Breast Carcinoma

description: The reemergence of HER2-positive breast carcinoma after a period of remission.


Anatomic Stage 0 Breast Cancer AJCC v8

description: Stage 0 includes: Tis, N0, M0. Tis: Ductal carcinoma in situ. Lobular carcinoma in situ is a benign entity and is removed from TNM staging in the AJCC Cancer Staging Manual, 8th Edition. N0: No regional lymph node metastasis is identified or isolated tumor cell clusters (ITCs) are identified only. M0: No clinical or radiographic evidence of distant metastases. Imaging studies are not required to assign the M0 category. (AJCC 8th ed.)


Stage IIIC Breast Cancer AJCC v6

description: Stage IIIC Breast Cancer was added in the 6th Edition AJCC Staging Manual, on the basis of metastasis to the infraclavicular lymph nodes (N3) plus any T, M0.


name: Hormone Receptor-Positive Breast Carcinoma

description: Breast adenocarcinoma that is positive for hormone receptors.


name: Refractory Hormone Receptor-Positive Breast Carcinoma

description: Hormone receptor-positive breast adenocarcinoma that does not respond to treatment.


breast leiomyosarcoma

description: An aggressive malignant smooth muscle neoplasm, arising from the breast. It is characterized by a proliferation of neoplastic spindle cells.


Malignant nipple neoplasm male

description: A malignant neoplasm that affects the area of the nipple in males.


name: Metastatic Breast Neuroendocrine Neoplasm

description: A neuroendocrine neoplasm that arises from the breast and has metastasized to another anatomic site.


name: Inflammatory carcinoma of breast stage III

description: Inflammatory breast carcinoma is classified as AJCC Stage IIIB (T4d) unless other criteria indicate more advanced staging.


name: High Grade Breast Mucoepidermoid Carcinoma

description: An aggressive mucoepidermoid carcinoma that arises from the breast. It is characterized by the presence of focal necrosis and high mitotic activity. Lymph node and distant metastases are common. The prognosis is usually poor.


Postradiation Breast Angiosarcoma

description: A malignant vascular neoplasm arising from the skin of the breast secondary to radiation treatment for breast cancer.


name: Progesterone Receptor-Positive Breast Carcinoma

description: Breast adenocarcinoma that is positive for progesterone receptors.


name: Invasive Breast Ductal Carcinoma and Invasive Lobular Carcinoma

description: An invasive ductal breast carcinoma associated with an invasive lobular carcinomatous component.


name: Metastatic Estrogen Receptor-Positive Breast Carcinoma

description: Estrogen receptor-positive breast carcinoma that has spread from its original site of growth to another anatomic site.


Multicentric Breast Carcinoma

description: A breast carcinoma characterized by the presence of multiple cancerous tumors that originate from different clones and are usually located in different quadrants of the breast.


name: Breast Cancer by AJCC v8 Prognostic Stage

description: A term that refers to the staging of breast cancer, following the rules of the TNM AJCC v8 classification system. This staging system should be used in countries where HER2, ER, and PR biomarker tests are routinely performed for patient care (U.S., Canada, etc.). (from AJCC 8th Ed.)


Stage IIIB Breast Carcinoma

description: Stage IIIB includes: (T4, N0, M0); (T4, N1, M0); (T4, N2, M0).  T4: Tumor of any size with direct extension to the chest wall and/or to the skin (ulceration or skin nodules).  N0: No regional lymph node metastasis.  N1: Metastasis to movable ipsilateral level I, II axillary lymph node(s).  N2: Metastases in ipsilateral level I, II axillary lymph nodes that are clinically fixed or matted; or in clinically detected ipsilateral internal mammary nodes in the absence of clinically evident axillary lymph node metastases.  M0: No clinical or radiographic evidence of distant metastasis.  M0 includes M0(i+).  (AJCC 7th Ed.)


name: Locally Advanced HER2-Negative Breast Carcinoma

description: A HER2-negative breast adenocarcinoma that has spread from its original site of growth to nearby tissues or lymph nodes.


name: Prognostic Stage IIB Breast Cancer AJCC v8

description: Stage IIB includes: (T0-1, N1, M0, G1, HER2 Status: Negative, ER Status: Negative, PR Status: Negative); (T0-1, N1, M0, G2, HER2 Status: Positive, ER Status: Positive, PR Status: Negative); (T0-1, N1, M0, G2, HER2 Status: Negative, ER Status: Positive, PR Status: Negative); (T0-1, N1, M0, G2, HER2 Status: Negative, ER Status: Negative, PR Status: Positive); (T0-1, N1, M0, G3, HER2 Status: Positive, ER Status: Positive, PR Status: Negative); (T0-1, N1, M0, G3, HER2 Status: Positive, ER Status: Negative, PR Status: Any); (T2, N0, M0, G1, HER2 Status: Negative, ER Status: Negative, PR Status: Negative); (T2, N0, M0, G2, HER2 Status: Positive, ER Status: Positive, PR Status: Negative); (T2, N0, M0, G2, HER2 Status: Negative, ER Status: Positive, PR Status: Negative); (T2, N0, M0, G2, HER2 Status: Negative, ER Status: Negative, PR Status: Positive); (T2, N0, M0, G3, HER2 Status: Positive, ER Status: Positive, PR Status: Negative); (T2, N0, M0, G3, HER2 Status: Positive, ER Status: Negative, PR Status: Any); (T2, N1, M0, G1, HER2 Status: Positive, ER Status: Any, PR Status: Any); (T2, N1, M0, G1, HER2 Status: Negative, ER Status: Negative, PR Status: Positive); (T0-2, N2, M0, G2, HER2 Status: Negative, ER Status: Positive, PR Status: Positive); (T0-2, N2, M0, G3, HER2 Status: Positive, ER Status: Positive, PR Status: Positive); (T3, N1-2, M0, G2, HER2 Status: Negative, ER Status: Positive, PR Status: Positive); (T3, N1-2, M0, G3, HER2 Status: Positive, ER Status: Positive, PR Status: Positive). T0: No evidence of primary tumor. T1: Tumor measuring 20 mm or less in greatest dimension. T2: Tumor measuring more than 20 mm, but not more than 50 mm in greatest dimension. T3: Tumor measuring more than 50 mm in greatest dimension. N0: No regional lymph node metastasis is identified or isolated tumor cell clusters (ITCs) are identified only. N1: Tumor with micrometastases; or metastases in 1-3 axillary lymph nodes; and/or clinically negative internal mammary nodes with micrometastases or macrometastases by sentinel lymph node biopsy. N2: Tumor with metastases in 4-9 axillary lymph nodes; or positive ipsilateral internal mammary lymph nodes by imaging in the absence of axillary lymph node metastases. G1: Low combined histologic grade (favorable); SBR score of 3-5 points. G2: Intermediate combined histologic grade (moderately favorable); SBR score: 6-7 points. G3: High combined histologic grade (unfavorable); SBR score of 8-9 points. M0: No clinical or radiographic evidence of distant metastases. Imaging studies are not required to assign the M0 category. (AJCC 8th ed.)


Invasive Male Breast Carcinoma

description: A rare invasive carcinoma that arises from the male breast. Morphologically, it is similar to the invasive carcinomas that arise from the female breast. It usually develops in the retroareolar region.


Anatomic Stage II Breast Cancer AJCC v8

description: Stage II includes: IIA: (T0, N1, M0); (T1, N1, M0); (T2, N0, M0); IIB: (T2, N1, M0); (T3, N0, M0). T0: No evidence of primary tumor. T1: Tumor measuring 20 mm or less in greatest dimension. T2: Tumor measuring more than 20 mm, but not more than 50 mm in greatest dimension. T3: Tumor measuring more than 50 mm in greatest dimension. N0: No regional lymph node metastasis is identified or isolated tumor cell clusters (ITCs) are identified only. N1: Tumor with micrometastases; or metastases in 1-3 axillary lymph nodes; and/or clinically negative internal mammary nodes with micrometastases or macrometastases by sentinel lymph node biopsy. M0: No clinical or radiographic evidence of distant metastases. Imaging studies are not required to assign the M0 category. (AJCC 8th ed.)


name: Low Grade Breast Adenosquamous Carcinoma

description: A low grade metaplastic carcinoma of the breast with morphologic features similar to the adenosquamous carcinoma of the skin.  In the majority of cases the prognosis is excellent.


name: Refractory Triple-Negative Breast Carcinoma

description: Triple-negative breast carcinoma that is resistant to treatment.


name: Noninfiltrating intraductal papillary adenocarcinoma (morphologic abnormality)

description: Breast ductal carcinoma in situ characterized by the presence of filiform arborizing fibrovascular cores lined by neoplastic ductal epithelium. (WHO 2019)


HER2-Low Breast Carcinoma

description: A breast adenocarcinoma defined by low expression of HER2 (IHC1+ or IHC2+; FISH negative).


name: Metastatic Breast Signet Ring Cell Carcinoma

description: A signet ring cell carcinoma that arises from the breast and has metastasized to other anatomic sites.


Breast adenocarcinoma metastatic

description: An adenocarcinoma that arises from the breast and has metastasized to another anatomic site.


name: Recurrent Estrogen Receptor-Positive Breast Carcinoma

description: The reemergence of estrogen receptor-positive breast carcinoma after a period of remission.


Stage II Breast Cancer AJCC v6 and v7

description: Stage II includes: IIA: (T0, N1, M0); (T1, N1, M0); (T2, N0, M0) and IIB: (T2, N1, M0); (T3, N0, M0).  T0: No evidence of primary tumor.  T1: Tumor 2.0 cm or less in greatest dimension.  T1 includes T1mi. T1mi: Tumor 1 mm or less in greatest dimension. T2: Tumor more than 2.0 cm but not more than 5.0 cm in greatest dimension.  T3: Tumor more than 5.0 cm in greatest dimension.  N1: Metastasis to movable ipsilateral axillary lymph node(s).  M0: No distant metastasis.  (AJCC 6th and 7th Eds.)


name: Inflammatory carcinoma of breast recurrent

description: The reemergence of inflammatory carcinoma of the breast after a period of remission


name: Breast Carcinoma with Choriocarcinomatous Features

description: An invasive ductal breast carcinoma, not otherwise specified, characterized by increased levels of human beta-chorionic gonadotropin in the serum.  Morphologic evidence of choriocarcinomatous differentiation is rare.